T-cell target antigens across major gynecologic cancers.

@article{RodrguezGarca2017TcellTA,
  title={T-cell target antigens across major gynecologic cancers.},
  author={Alba Rodr{\'i}guez-Garc{\'i}a and Nicholas G Minutolo and J. Michael Robinson and Daniel James Powell},
  journal={Gynecologic oncology},
  year={2017},
  volume={145 3},
  pages={426-435}
}
Immunotherapies have achieved remarkable success in treating different forms of cancer including melanoma, non-small cell lung carcinoma, bladder cancer, synovial cell sarcoma, and multiple myeloma using immune checkpoint blockade or gene-engineered T-cells. Although gynecologic cancers have not been historically classified as immunogenic tumors, growing evidence has shown that they are in fact able to elicit endogenous antitumor immune responses suggesting that patients with these cancers may… CONTINUE READING
3 Citations
90 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 90 references

Mutated tumor neoantigens are recognized by tumor infiltrating lymphocytes from metastatic ovarian cancer

  • Deniger, D.C.P, +7 authors Steven A. Rosenberg
  • 2016
Highly Influential
10 Excerpts

Similar Papers

Loading similar papers…